Heliang Liu

1.7k total citations
80 papers, 1.3k citations indexed

About

Heliang Liu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Heliang Liu has authored 80 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Heliang Liu's work include Occupational and environmental lung diseases (24 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Lymphatic System and Diseases (6 papers). Heliang Liu is often cited by papers focused on Occupational and environmental lung diseases (24 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers) and Lymphatic System and Diseases (6 papers). Heliang Liu collaborates with scholars based in China, United States and Hong Kong. Heliang Liu's co-authors include Hwa‐Yaw Tam, Hong Xu, P. K. A. Wai, Xinhuan Feng, Siu Wing Or, M.S. Demokan, Tian Li, Wenchen Cai, Fuyu Jin and Xinyu Yang and has published in prestigious journals such as The Journal of Immunology, The Science of The Total Environment and Scientific Reports.

In The Last Decade

Heliang Liu

76 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heliang Liu China 20 354 310 298 191 116 80 1.3k
Daizong Li China 12 212 0.6× 371 1.2× 113 0.4× 65 0.3× 49 0.4× 24 891
Bang Liu China 18 117 0.3× 1.0k 3.2× 65 0.2× 106 0.6× 96 0.8× 57 1.7k
Wentao Yue China 22 214 0.6× 549 1.8× 93 0.3× 19 0.1× 111 1.0× 114 1.4k
Chen Shi China 19 52 0.1× 375 1.2× 62 0.2× 63 0.3× 52 0.4× 61 1.1k
Patricia Leroyer France 20 68 0.2× 266 0.9× 113 0.4× 26 0.1× 128 1.1× 38 2.6k
Yoshiyuki Saito Japan 16 82 0.2× 520 1.7× 50 0.2× 40 0.2× 57 0.5× 85 1.2k
Ki Hyung Kim South Korea 22 124 0.4× 465 1.5× 118 0.4× 19 0.1× 184 1.6× 120 1.7k
Shih‐Chia Liu Taiwan 16 61 0.2× 272 0.9× 97 0.3× 60 0.3× 52 0.4× 57 787
Wenyan Wang China 21 147 0.4× 776 2.5× 46 0.2× 57 0.3× 248 2.1× 79 2.0k

Countries citing papers authored by Heliang Liu

Since Specialization
Citations

This map shows the geographic impact of Heliang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heliang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heliang Liu more than expected).

Fields of papers citing papers by Heliang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heliang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heliang Liu. The network helps show where Heliang Liu may publish in the future.

Co-authorship network of co-authors of Heliang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Heliang Liu. A scholar is included among the top collaborators of Heliang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heliang Liu. Heliang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shupeng, Frederic Y. M. Wan, Heliang Liu, et al.. (2025). The regulatory role of FABP4 in macrophage polarization and lipid accumulation in silicosis. Cellular Signalling. 135. 112041–112041. 1 indexed citations
2.
Li, Tian, Na Mao, Jianing Wang, et al.. (2024). Paeoniflorin mitigates MMP-12 inflammation in silicosis via Yang-Yin-Qing-Fei Decoction in murine models. Phytomedicine. 129. 155616–155616. 7 indexed citations
3.
He, Hailan, Jingsi Wang, Yuxi Zhang, et al.. (2024). miR-455–3p regulates lymphangiogenesis in silicosis by regulating VEGF-C/VEGFR3. Ecotoxicology and Environmental Safety. 278. 116444–116444. 3 indexed citations
4.
Hao, Xiaohui, Shifeng Li, Jie Cui, et al.. (2023). Inhibition of Oncogenic Src Ameliorates Silica-Induced Pulmonary Fibrosis via PI3K/AKT Pathway. International Journal of Molecular Sciences. 24(1). 774–774. 13 indexed citations
5.
Zhang, Chuan‐Xi, Ziyan Zhang, Heliang Liu, et al.. (2023). Long-Term Administration of LL-37 Can Induce Irreversible Rosacea-like Lesion. Current Issues in Molecular Biology. 45(4). 2703–2716. 13 indexed citations
6.
Jin, Fuyu, Yaqian Li, Tian Li, et al.. (2022). Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica. Journal of Visualized Experiments.
7.
Xu, Mengying, Lan Zhao, Haoming Zhang, et al.. (2022). Quercetin Alleviates Pulmonary Fibrosis in Mice Exposed to Silica by Inhibiting Macrophage Senescence. Frontiers in Pharmacology. 13. 912029–912029. 26 indexed citations
8.
Liu, Heliang, et al.. (2022). Cyclophilin A accelerates SiO2-induced macrophage foaming. Cellular Signalling. 103. 110562–110562. 2 indexed citations
9.
Cui, Jie, Hailan He, Hong Xu, et al.. (2022). The regulatory effect of pulmonary lymphatic drainage on silicosis fibrosis. Ecotoxicology and Environmental Safety. 241. 113758–113758. 4 indexed citations
10.
Li, Tian, Xinyu Yang, Dingjie Xu, et al.. (2021). OC‐STAMP Overexpression Drives Lung Alveolar Epithelial Cell Type II Senescence in Silicosis. Oxidative Medicine and Cellular Longevity. 2021(1). 4158495–4158495. 13 indexed citations
11.
Cui, Jie, Xinying Li, Xiaohui Hao, et al.. (2021). Increased secretion of VEGF-C from SiO2-induced pulmonary macrophages promotes lymphangiogenesis through the Src/eNOS pathway in silicosis. Ecotoxicology and Environmental Safety. 218. 112257–112257. 12 indexed citations
12.
Li, Ning, Luyao Wang, Kun Sun, et al.. (2021). Silica nanoparticle induces pulmonary fibroblast transdifferentiation via macrophage route: Potential mechanism revealed by proteomic analysis. Toxicology in Vitro. 76. 105220–105220. 19 indexed citations
13.
Cai, Wenchen, Hong Xu, Bonan Zhang, et al.. (2020). Differential expression of lncRNAs during silicosis and the role of LOC103691771 in myofibroblast differentiation induced by TGF-β1. Biomedicine & Pharmacotherapy. 125. 109980–109980. 21 indexed citations
14.
Ma, Dong, Bin Zheng, Heliang Liu, et al.. (2020). Klf5 down-regulation induces vascular senescence through eIF5a depletion and mitochondrial fission. PLoS Biology. 18(8). e3000808–e3000808. 56 indexed citations
15.
Gao, Xuemin, Hong Xu, Dingjie Xu, et al.. (2020). MiR-411–3p alleviates Silica-induced pulmonary fibrosis by regulating Smurf2/TGF-β signaling. Experimental Cell Research. 388(2). 111878–111878. 26 indexed citations
16.
Chen, Yingying, Dingjie Xu, Zhongqiu Wei, et al.. (2019). Inhibition of miR-155-5p Exerts Anti-Fibrotic Effects in Silicotic Mice by Regulating Meprin α. Molecular Therapy — Nucleic Acids. 19. 350–360. 31 indexed citations
17.
Shi, Hai Yun, et al.. (2012). Expression of MSP58 in human colorectal cancer and its correlation with prognosis. Medical Oncology. 29(5). 3136–3142. 10 indexed citations
18.
Shi, Hai Yun, Yi Zhou, Heliang Liu, et al.. (2010). Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis. BMC Cancer. 10(1). 477–477. 20 indexed citations
19.
Qin, Jun, Jianlin Yuan, Ling Li, et al.. (2008). In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells. Biomedicine & Pharmacotherapy. 63(3). 241–248. 22 indexed citations
20.
Ameredes, Bill T., Rubén Zamora, Jigme M. Sethi, et al.. (2005). Alterations in Nitric Oxide and Cytokine Production with Airway Inflammation in the Absence of IL-10. The Journal of Immunology. 175(2). 1206–1213. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daizong Li Breakdown of academic impact, for papers by Bang Liu Breakdown of academic impact, for papers by Wentao Yue Breakdown of academic impact, for papers by Chen Shi Breakdown of academic impact, for papers by Patricia Leroyer Breakdown of academic impact, for papers by Yoshiyuki Saito Breakdown of academic impact, for papers by Ki Hyung Kim Breakdown of academic impact, for papers by Shih‐Chia Liu Breakdown of academic impact, for papers by Wenyan Wang
Rankless by CCL
2026